TDP-43 proteinopathy in familial motor neurone disease with TARDBP A315T mutation: a case report.
作者信息
Cairns N J, Perrin R J, Schmidt R E, Gru A, Green K G, Carter D, Taylor-Reinwald L, Morris J C, Gitcho M A, Baloh R H
出版信息
Neuropathol Appl Neurobiol. 2010 Dec;36(7):673-9. doi: 10.1111/j.1365-2990.2010.01121.x.
Abstract
摘要
相似文献
1
TDP-43 proteinopathy in familial motor neurone disease with TARDBP A315T mutation: a case report.
Neuropathol Appl Neurobiol. 2010 Dec;36(7):673-9. doi: 10.1111/j.1365-2990.2010.01121.x.
2
TDP-43 A315T mutation in familial motor neuron disease.
Ann Neurol. 2008 Apr;63(4):535-8. doi: 10.1002/ana.21344. Epub 2008 Feb 20.
3
RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy.
Brain. 2019 Dec 1;142(12):3753-3770. doi: 10.1093/brain/awz313.
4
Co-occurrence of progressive anarthria with an S393L TARDBP mutation and ALS within a family.
Amyotroph Lateral Scler. 2012 Jan;13(1):155-7. doi: 10.3109/17482968.2011.598168. Epub 2011 Aug 11.
5
Progressive motor weakness in transgenic mice expressing human TDP-43.
Neurobiol Dis. 2010 Nov;40(2):404-14. doi: 10.1016/j.nbd.2010.06.017. Epub 2010 Aug 2.
6
TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43.
J Alzheimers Dis. 2013;33 Suppl 1(Suppl 1):S35-45. doi: 10.3233/JAD-2012-129036.
7
Clinical aspects of TDP-43 proteinopathy, neurofilament inclusion body disease and dementias lacking distinctive proteinopathy.
Handb Clin Neurol. 2008;89:377-82. doi: 10.1016/S0072-9752(07)01235-3.
8
Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.
J Neurosci. 2016 Jul 20;36(29):7707-17. doi: 10.1523/JNEUROSCI.1457-16.2016.
9
Survival in the pre-senile dementia frontotemporal lobar degeneration with TDP-43 proteinopathy: effects of genetic, demographic and neuropathological variables.
Folia Neuropathol. 2016;54(2):137-48. doi: 10.5114/fn.2016.60391.
10
First Japanese autopsy case showing LRRK2 mutation G2019S and TDP-43 proteinopathy.
Parkinsonism Relat Disord. 2021 Oct;91:85-87. doi: 10.1016/j.parkreldis.2021.09.009. Epub 2021 Sep 15.
引用本文的文献
1
The D2 Dopamine Receptor Interferes With the Protective Effect of the A Adenosine Receptor on TDP-43 Mislocalization in Experimental Models of Motor Neuron Degeneration.
Front Neurosci. 2018 Mar 20;12:187. doi: 10.3389/fnins.2018.00187. eCollection 2018.
2
TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
Nat Neurosci. 2018 Feb;21(2):228-239. doi: 10.1038/s41593-017-0047-3. Epub 2018 Jan 8.
3
From animal models to human disease: a genetic approach for personalized medicine in ALS.
Acta Neuropathol Commun. 2016 Jul 11;4(1):70. doi: 10.1186/s40478-016-0340-5.
4
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.
Acta Neuropathol. 2015 Apr;129(4):469-91. doi: 10.1007/s00401-014-1380-1. Epub 2014 Dec 31.
5
An ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel β-structure and induces TDP-43 redistribution.
Hum Mol Genet. 2014 Dec 20;23(25):6863-77. doi: 10.1093/hmg/ddu409. Epub 2014 Aug 11.
6
The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum.
Ann Med. 2012 Dec;44(8):817-28. doi: 10.3109/07853890.2012.665471. Epub 2012 Mar 16.
7
Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS.
Hum Mol Genet. 2011 Jun 15;20(12):2308-21. doi: 10.1093/hmg/ddr124. Epub 2011 Mar 26.
本文引用的文献
1
TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3858-63. doi: 10.1073/pnas.0912417107. Epub 2010 Feb 3.
2
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration.
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18809-14. doi: 10.1073/pnas.0908767106. Epub 2009 Oct 15.
3
TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy.
Acta Neuropathol. 2009 Nov;118(5):633-45. doi: 10.1007/s00401-009-0571-7. Epub 2009 Jul 18.
4
TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration.
Ann Neurol. 2009 Apr;65(4):470-3. doi: 10.1002/ana.21612.
5
Rethinking ALS: the FUS about TDP-43.
Cell. 2009 Mar 20;136(6):1001-4. doi: 10.1016/j.cell.2009.03.006.
6
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.
Science. 2009 Feb 27;323(5918):1208-1211. doi: 10.1126/science.1165942.
7
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.
Science. 2009 Feb 27;323(5918):1205-8. doi: 10.1126/science.1166066.
8
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations.
Eur J Neurol. 2009 Jun;16(6):727-32. doi: 10.1111/j.1468-1331.2009.02574.x. Epub 2009 Feb 19.
9
Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis.
J Med Genet. 2009 Feb;46(2):112-4. doi: 10.1136/jmg.2008.062463. Epub 2008 Oct 17.
10
Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
PLoS Genet. 2008 Sep 19;4(9):e1000193. doi: 10.1371/journal.pgen.1000193.
Zotero 插件